Robert P. McCabe

2.3k total citations
34 papers, 1.0k citations indexed

About

Robert P. McCabe is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Robert P. McCabe has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 16 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Robert P. McCabe's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (13 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Robert P. McCabe is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (13 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Robert P. McCabe collaborates with scholars based in United States, Canada and Netherlands. Robert P. McCabe's co-authors include Charles O. Elson, Yingzi Cong, John P. Sundberg, Steven L. Brandwein, E H Birkenmeier, A Lazenby, Philip A. W. Dean, David I. Weinberg, Marion G. Peters and Heather Secrist and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

Robert P. McCabe

33 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert P. McCabe United States 15 496 416 356 232 173 34 1.0k
Haggai Bar‐Yoseph Israel 14 347 0.7× 187 0.4× 290 0.8× 119 0.5× 269 1.6× 39 906
Kenneth J. Gorelick United States 12 324 0.7× 317 0.8× 164 0.5× 70 0.3× 133 0.8× 34 796
Manuel Álvarez-Lobos Chile 15 247 0.5× 202 0.5× 281 0.8× 194 0.8× 292 1.7× 41 893
Chiedzo Mpofu United Kingdom 6 418 0.8× 137 0.3× 255 0.7× 169 0.7× 412 2.4× 10 988
Naamah Zitomersky United States 13 203 0.4× 273 0.7× 133 0.4× 89 0.4× 359 2.1× 17 853
Jin Imai Japan 10 174 0.4× 138 0.3× 137 0.4× 134 0.6× 349 2.0× 36 828
Shin Sasaki Japan 20 155 0.3× 471 1.1× 262 0.7× 207 0.9× 335 1.9× 56 1.5k
Ira Shafran United States 16 787 1.6× 293 0.7× 821 2.3× 296 1.3× 172 1.0× 44 1.2k
Aurélie Couturier-Maillard France 10 144 0.3× 249 0.6× 88 0.2× 134 0.6× 475 2.7× 10 783
Henrik Permin Denmark 20 74 0.1× 437 1.1× 148 0.4× 117 0.5× 133 0.8× 60 1.1k

Countries citing papers authored by Robert P. McCabe

Since Specialization
Citations

This map shows the geographic impact of Robert P. McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. McCabe more than expected).

Fields of papers citing papers by Robert P. McCabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. McCabe. The network helps show where Robert P. McCabe may publish in the future.

Co-authorship network of co-authors of Robert P. McCabe

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. McCabe. A scholar is included among the top collaborators of Robert P. McCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. McCabe. Robert P. McCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herfarth, Hans, Anita Afzali, Monika Fischer, et al.. (2023). Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry. Clinical and Translational Gastroenterology. 15(3). e00669–e00669. 1 indexed citations
2.
Long, Millie D., Anita Afzali, Monika Fischer, et al.. (2022). Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Inflammatory Bowel Diseases. 29(4). 570–578. 18 indexed citations
3.
McCabe, Robert P., et al.. (2020). Adalimumab Concentration Changes After Dose Escalation in Inflammatory Bowel Disease. Therapeutic Drug Monitoring. 43(5). 645–651. 2 indexed citations
4.
Batts, Kenneth P., et al.. (2020). Significance of serrated epithelial change in inflammatory bowel disease. Postgraduate Medicine. 133(1). 66–70. 10 indexed citations
5.
McCabe, Robert P., Monika Fischer, Benjamin Cohen, et al.. (2019). P056 Methodology and Initial Results From TOUR (Tofacitinib Response in Ulcerative Colitis): A Real World Prospective Multicenter Study. The American Journal of Gastroenterology. 114(1). S15–S15. 1 indexed citations
6.
Kattah, Michael G., Jeffrey M. Milush, Trevor D. Burt, et al.. (2018). Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Clinical and Translational Gastroenterology. 9(4). e143–e143. 25 indexed citations
7.
Sanduleanu, Silvia, Tonya Kaltenbach, Alan Barkun, et al.. (2015). A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointestinal Endoscopy. 83(1). 213–222. 22 indexed citations
8.
Osterman, Mark T., Faten Aberra, Raymond K. Cross, et al.. (2014). Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 12(11). 1887–1893.e3. 65 indexed citations
9.
Batts, Kenneth P., et al.. (2012). Mo1705 Flat Serrated Change: Does it Predict the Development of Colonic Mucosal Dysplasia in Inflammatory Bowel Disease?. Gastroenterology. 142(5). S–665. 8 indexed citations
10.
Weinberg, David I., et al.. (2007). Long-Term Durability of Crohn’s Disease Treatment with Infliximab. Digestive Diseases and Sciences. 53(4). 1033–1041. 44 indexed citations
11.
McCabe, Robert P.. (2002). Gastrointestinal manifestations of non-AIDS immunodeficiency. Current Treatment Options in Gastroenterology. 5(1). 17–25. 16 indexed citations
12.
McCabe, Robert P., et al.. (2001). Distal esophageal perforation caused by tuberculosis. Journal of Thoracic and Cardiovascular Surgery. 121(5). 1003–1004. 17 indexed citations
13.
Cong, Yingzi, Steven L. Brandwein, Robert P. McCabe, et al.. (1998). CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease. The Journal of Experimental Medicine. 187(6). 855–864. 313 indexed citations
14.
Elson, Charles O., Yingzi Cong, Steven L. Brandwein, et al.. (1998). Experimental Models to Study Molecular Mechanisms Underlying Intestinal Inflammation. Annals of the New York Academy of Sciences. 859(1). 85–95. 67 indexed citations
15.
Seibold, Frank, Beatrice Seibold-Schmid, Yingzi Cong, et al.. (1998). Regional differences in L-selectin expression in murine intestinal lymphocytes☆☆☆. Gastroenterology. 114(5). 965–974. 14 indexed citations
16.
Brandwein, Steven L., Robert P. McCabe, Yingzi Cong, et al.. (1997). Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. The Journal of Immunology. 159(1). 44–52. 123 indexed citations
17.
McCabe, Robert P., et al.. (1996). A new therapeutic option for the treatment of pneumonia. The American Journal of Medicine. 100(6). 60S–67S. 34 indexed citations
18.
McCabe, Robert P., et al.. (1993). Cytokine mRNA Expression in Intestine from Normal and Inflammatory Bowel Disease Patients. Clinical Immunology and Immunopathology. 66(1). 52–58. 74 indexed citations
19.
Edelstein, Howard, et al.. (1991). A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia. Journal of Antimicrobial Chemotherapy. 28(4). 569–575. 26 indexed citations
20.
Chirurgi, Valerie A., Howard Edelstein, & Robert P. McCabe. (1990). Pneumococcal Bacteremia as a Marker for Human Immunodeficiency Virus Infection in Patients Without AIDS. Southern Medical Journal. 83(8). 895–899. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haggai Bar‐Yoseph Breakdown of academic impact, for papers by Kenneth J. Gorelick Breakdown of academic impact, for papers by Manuel Álvarez-Lobos Breakdown of academic impact, for papers by Chiedzo Mpofu Breakdown of academic impact, for papers by Naamah Zitomersky Breakdown of academic impact, for papers by Jin Imai Breakdown of academic impact, for papers by Shin Sasaki Breakdown of academic impact, for papers by Ira Shafran Breakdown of academic impact, for papers by Aurélie Couturier-Maillard Breakdown of academic impact, for papers by Henrik Permin
Rankless by CCL
2026